Accessibility: Skip TopNav
Study 4 (1002-048) – LDL-C Efficacy Primary Endpoint
Percent Change from Baseline after 12 Weeks of Dosing of Bempedoic Acid 180mg
Format
JPEG
Source
Esperion Therapeutics, Inc.
Downloads
Original
Large
Medium
Small